These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31837259)

  • 1. Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor.
    Wahyuni TS; Mahfud H; Permatasari AA; Widyawaruyanti A; Fuad A
    J Basic Clin Physiol Pharmacol; 2019 Dec; 30(6):. PubMed ID: 31837259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells.
    Rehman S; Ashfaq UA; Ijaz B; Riazuddin S
    Microb Pathog; 2018 Aug; 121():198-209. PubMed ID: 29775725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hepatitis C virus replication by chalepin and pseudane IX isolated from Ruta angustifolia leaves.
    Wahyuni TS; Widyawaruyanti A; Lusida MI; Fuad A; Soetjipto ; Fuchino H; Kawahara N; Hayashi Y; Aoki C; Hotta H
    Fitoterapia; 2014 Dec; 99():276-83. PubMed ID: 25454460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Hepatitis C Virus Activity of a Crude Extract from Longan (Dimocarpus longan Lour.) Leaves.
    Apriyanto DR; Aoki C; Hartati S; Hanafi M; Kardono LB; Arsianti A; Louisa M; Sudiro TM; Dewi BE; Sudarmono P; Soebandrio A; Hotta H
    Jpn J Infect Dis; 2016 May; 69(3):213-20. PubMed ID: 26255732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors.
    Li YP; Ramirez S; Humes D; Jensen SB; Gottwein JM; Bukh J
    Gastroenterology; 2014 Mar; 146(3):812-821.e4. PubMed ID: 24262279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens.
    Cento V; Nguyen THT; Di Carlo D; Biliotti E; Gianserra L; Lenci I; Di Paolo D; Calvaruso V; Teti E; Cerrone M; Romagnoli D; Melis M; Danieli E; Menzaghi B; Polilli E; Siciliano M; Nicolini LA; Di Biagio A; Magni CF; Bolis M; Antonucci FP; Di Maio VC; Alfieri R; Sarmati L; Casalino P; Bernardini S; Micheli V; Rizzardini G; Parruti G; Quirino T; Puoti M; Babudieri S; D'Arminio Monforte A; Andreoni M; Craxì A; Angelico M; Pasquazzi C; Taliani G; Guedj J; Perno CF; Ceccherini-Silberstein F
    PLoS One; 2017; 12(5):e0177352. PubMed ID: 28545127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugs.
    Permanasari AA; Aoki-Utsubo C; Wahyuni TS; Tumewu L; Adianti M; Widyawaruyanti A; Hotta H; Hafid AF
    BMC Complement Med Ther; 2021 Oct; 21(1):260. PubMed ID: 34641875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Activity of Simeprevir against Hepatitis C Virus Genotype 1 Clinical Isolates and Its Correlation with NS3 Sequence and Site-Directed Mutants.
    Verbinnen T; Fevery B; Vijgen L; Jacobs T; De Meyer S; Lenz O
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7548-57. PubMed ID: 26392483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.
    Bachmetov L; Gal-Tanamy M; Shapira A; Vorobeychik M; Giterman-Galam T; Sathiyamoorthy P; Golan-Goldhirsh A; Benhar I; Tur-Kaspa R; Zemel R
    J Viral Hepat; 2012 Feb; 19(2):e81-8. PubMed ID: 22239530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source.
    Ravikumar YS; Ray U; Nandhitha M; Perween A; Raja Naika H; Khanna N; Das S
    Virus Res; 2011 Jun; 158(1-2):89-97. PubMed ID: 21440018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portulaca oleracea L. as a Prospective Candidate Inhibitor of Hepatitis C Virus NS3 Serine Protease.
    Noreen S; Hussain I; Tariq MI; Ijaz B; Iqbal S; Qamar-ul-Zaman ; Ashfaq UA; Husnain T
    Viral Immunol; 2015 Jun; 28(5):282-9. PubMed ID: 25871297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
    McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
    J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric mice.
    Shi N; Hiraga N; Imamura M; Hayes CN; Zhang Y; Kosaka K; Okazaki A; Murakami E; Tsuge M; Abe H; Aikata H; Takahashi S; Ochi H; Tateno-Mukaidani C; Yoshizato K; Matsui H; Kanai A; Inaba T; McPhee F; Gao M; Chayama K
    Gut; 2013 Jul; 62(7):1055-61. PubMed ID: 23322441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Andrographolide exerts anti-hepatitis C virus activity by up-regulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells.
    Lee JC; Tseng CK; Young KC; Sun HY; Wang SW; Chen WC; Lin CK; Wu YH
    Br J Pharmacol; 2014 Jan; 171(1):237-52. PubMed ID: 24117426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Anti-HCV Activity of Multiple Punica granatum Extracts and Fractions in Virus-infected Human Hepatocytes.
    Rehman S; Ashfaq UA; Ijaz B; Jabeen Z; Riazuddin S
    Curr Pharm Biotechnol; 2018; 19(15):1221-1231. PubMed ID: 30608038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinations of lambda interferon with direct-acting antiviral agents are highly efficient in suppressing hepatitis C virus replication.
    Friborg J; Levine S; Chen C; Sheaffer AK; Chaniewski S; Voss S; Lemm JA; McPhee F
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1312-22. PubMed ID: 23274666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of Pycnogenol® on hepatitis C virus replication.
    Ezzikouri S; Nishimura T; Kohara M; Benjelloun S; Kino Y; Inoue K; Matsumori A; Tsukiyama-Kohara K
    Antiviral Res; 2015 Jan; 113():93-102. PubMed ID: 25446333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies.
    Lenz O; Verbinnen T; Fevery B; Tambuyzer L; Vijgen L; Peeters M; Buelens A; Ceulemans H; Beumont M; Picchio G; De Meyer S
    J Hepatol; 2015 May; 62(5):1008-14. PubMed ID: 25445400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric mice.
    Ohara E; Hiraga N; Imamura M; Iwao E; Kamiya N; Yamada I; Kono T; Onishi M; Hirata D; Mitsui F; Kawaoka T; Tsuge M; Takahashi S; Abe H; Hayes CN; Ochi H; Tateno C; Yoshizato K; Tanaka S; Chayama K
    J Hepatol; 2011 May; 54(5):872-8. PubMed ID: 21145818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary screening of activity fraction of Alchornea trewioides suppresses expression of subgenomic hepatitis C virus RNA in vitro].
    Wang QR; Tao HM; Wu G; Fan Q; Huang SH; Hong F; Lv ZP
    Zhong Yao Cai; 2013 Jun; 36(6):880-3. PubMed ID: 24380267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.